Novartis is launching a…
Novartis is launching a three-front push to close healthcare gaps [...]
Too much information, uncertainty…
Too much information, uncertainty and financial worries are hitting Americans [...]
Amneal and BioCorRx have earned…
Amneal and BioCorRx have earned the ire of the FDA’s [...]
After more than a decade in charge…
After more than a decade in charge of the most [...]
Japan’s Shionogi is joining the…
Japan’s Shionogi is joining the spate of drugmakers to unveil [...]
The company is moving out of the…
The company is moving out of the building that used [...]
Biogen has agreed to a settlement…
Biogen has agreed to a settlement with investors who claimed [...]
With a solid year of double-digit…
With a solid year of double-digit revenue growth in the [...]
Johnson & Johnson’s…
Johnson & Johnson’s immunology drug Tremfya is looking to challenge [...]
The plummeting demand for…
The plummeting demand for Merck’s HPV vaccine Gardasil in China [...]